Observational Study of Chronic Myeloid Leukemia Patients Collecting Real-Life Clinical and Biological Data Over Long-Term Follow-Up

What this Trial Is About

Researchers are creating the largest possible real-life group of patients with Chronic Myeloid Leukemia CML to collect long-term follow-up data. This observational study aims to analyze epidemiological trends, identify patient subgroups based on treatment response, evaluate new medications used in everyday care, study treatment discontinuations, and assess the effects of evolving treatment recommendations. The study collects clinical and biological information from CML patients both prospectively and retrospectively starting from diagnosis. Data gathering continues throughout the long-term follow-up period, even after treatment has stopped. There are no specific drugs or interventions administered in this observational study it focuses on monitoring and recording real-world patient experiences and responses. Participants provide data throughout their disease course, which may be collected for up to 30 years or until death or last follow-up. Researchers evaluate multiple outcomes including molecular and cytogenetic responses, treatment efficacy and tolerance, prognosis scores at diagnosis, body measurements, and medical history related to CML. This extensive monitoring helps better understand CML progression and treatment in real-life settings.

Chronic Myeloid Leukemia (CML) Real-Life Database